Zentalis Pharmaceuticals Cash from Financing (TTM) Trends

Zentalis Pharmaceuticals Inc (ZNTL)

10.98 -0.78 (-6.67%) USD | NASDAQ | Apr 25, 16:00

10.98 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	237.30M
September 30, 2023	287.04M
June 30, 2023	287.32M
March 31, 2023	260.16M
December 31, 2022	261.04M
September 30, 2022	223.57M
June 30, 2022	389.55M
March 31, 2022	179.78M
December 31, 2021	178.52M

Date	Value
September 30, 2021	165.66M
June 30, 2021	154.99M
March 31, 2021	346.96M
December 31, 2020	360.44M
September 30, 2020	360.98M
June 30, 2020	286.96M
March 31, 2020	95.30M
December 31, 2019	81.83M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

81.83M

Minimum

Dec 2019

389.55M

Maximum

Jun 2022

244.55M

Average

260.16M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks